ReviewAcademic radiology2017
Missteps in Current Estimates of Cancer Overdiagnosis.
Review in Academic radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Article
- Effectiveness of Mammography Screening on Breast Cancer Mortality - A Study Protocol for Emulation of Target Trials Using German Health Claims Data.Clinical epidemiology · 2022Article
- Optimal Screening in Breast Cancer Survivors With Dense Breasts on Mammography.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Article
- Impact of New Technology Adoption on Breast Cancer Screening.Radiology · 2019Article
- Breast cancer in women 40-50 and over 70 years of age: the need for screening in Brazil.Radiologia brasileiraReview
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
Abstract
The balance between the benefits and harms of imaging-based cancer screening continues to be an area of controversy and widespread media attention. Of the potential harms, overdiagnosis from screening is likely the most elusive in estimating and quantifying. This article describes the major methodological issues with recently reported estimates of overdiagnosis that are based on excess cancer incidence, and suggests that modeling focused on tumor lead-time can serve as a complementary method for excess incidence-based overdiagnosis estimates. Radiologists should be conversant on the topic of overdiagnosis and understand the limitations of different methods used to estimate its magnitude.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.